SCHEMBL3136016

SCHEMBL3136016

Cc1nn(CC(C)N)c2cc(O)ccc12

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 8/20 0.56
HTR2C P28335 8/20 0.56
HTR2B P41595 3/20 0.56
HTR1A P08908 2/20 0.56
ADRA2A P08913 2/20 0.56
ADRA2B P18089 2/20 0.56
ADRA2C P18825 2/20 0.56
HTR1D P28221 1/20 0.56
HTR7 P34969 1/20 0.56
HTR4 Q13639 1/20 0.56
ESR1 P03372 4/20 0.43
KMO O15229 1/20 0.40
ADORA2A P29274 2/20 0.39
ADORA2B P29275 2/20 0.39
SLC22A12 Q96S37 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL4845606 0.90 HTR2A (0.47) HTR2AHTR2CHTR2BHTR1AADRA2A
Fumaric Acid SCHEMBL4845619 0.90 HTR2A (0.47) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL6360534 0.84 HTR2A (0.55) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL905840 0.80 HTR2C (0.58) HTR2AHTR2CHTR2BSLC22A12
SCHEMBL18853871 0.80 ESR1 (0.63) ESR1KMOADORA2AADORA2BSLC22A12
SCHEMBL6364909 0.78 GLS (0.57) HTR2AHTR2CHTR2BHTR1AADRA2A
Fumaric Acid SCHEMBL7098345 0.78 HTR2C (0.40) HTR2AHTR2CHTR2BHTR1AADRA2A
Fumaric Acid SCHEMBL7098346 0.78 HTR2C (0.40) HTR2AHTR2CHTR2BHTR1AADRA2A
SCHEMBL4845615 0.77 SLC22A12 (0.42) HTR2AHTR2CHTR2BHTR1AADRA2A
Fumaric Acid SCHEMBL6361127 0.76 HTR2A (0.46) HTR2AHTR2CHTR2BHTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513589-B1 1,5-DISUBSTITUTED PYRROLID-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF EYE DISEASES SUCH AS GLAUCOMA MERCK FROSST CANADA LTD (CA) 2010-11-10 EP claimed
EP-1613621-B1 PROSTAGLANDIN ANALOGS AS EP4 RECEPTOR AGONISTS MERCK FROSST CANADA LTD (CA) 2010-07-21 EP claimed
EP-1663987-B1 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-03-18 EP claimed
US-6956036-B1 6-hydroxy-indazole derivatives for treating glaucoma ALCON, INC. (CH) 2005-10-18 US disclosed